世界各国のリアルタイムなデータ・インテリジェンスで皆様をお手伝い

Global Gastrointestinal Endoscopy Market

Global Gastrointestinal Endoscopy Market


The global gastrointestinal endoscopy market, is expected to reach USD 18,798,321.84 thousand by 2032 from USD 12,066,210.00 thousand in 2024, growing at a substantial CAGR of 5.8% in the forecast ... もっと見る

 

 

出版社 出版年月 電子版価格 納期 言語
Data Bridge Market Research
データブリッジマーケットリサーチ
2025年6月1日 US$3,500
シングルユーザライセンス
ライセンス・価格情報
注文方法はこちら
2-3営業日以内 英語

※当ページの内容はウェブ更新時の情報です。
最新版の価格やページ数などの情報についてはお問合せください。

日本語のページは自動翻訳を利用し作成しています。
実際のレポートは英文のみでご納品いたします。


 

Summary

The global gastrointestinal endoscopy market, is expected to reach USD 18,798,321.84 thousand by 2032 from USD 12,066,210.00 thousand in 2024, growing at a substantial CAGR of 5.8% in the forecast period of 2025 to 2032.
Market Segmentation:
Global Gastrointestinal Endoscopy Market, Product (Gastrointestinal Endoscopes & Systems and Gastrointestinal Endotherapy), Application (Treatment and Diagnosis), Procedure Type (Colonoscopy, Gastroscopy, Duodenoscopy, Enteroscopy, Sigmoidoscopy and Others), Usability (Reusable and Disposable/ Single Use), End User (Hospitals, Ambulatory Surgical Centers, Specialty Clinics, Laboratories, and Others), Distribution Channel (Direct Tender, Retail Sales, and Others), Country (U.S., Canada, Mexico, Germany, U.K., France, Russia, Italy, Spain, Turkey, Poland, Netherlands, Switzerland, And Rest Of Europe, China, Japan, India, Australia, South Korea, Singapore, Thailand, Philippines, Malaysia, Indonesia, Vietnam, Rest Of Asia-Pacific, Brazil, Argentina, And Rest Of South America, Saudi Arabia, U.A.E., South Africa, Egypt, Kuwait, Israel, And Rest Of Middle East And Africa) -Industry Trends & Forecast To 2032

Overview of the Global Gastrointestinal Endoscopy are:

Driver

• Rising Prevalence of Gastrointestinal Disorders

Restrain

• High Cost of Equipment and Procedures
Opportunity

• Growing Emphasis on Early Colorectal Cancer Detection

Market Players:

The key market players for global Gastrointestinal Endoscopy are listed below:

• Medtronic (Ireland)
• Stryker (U.S.)
• Johnson & Johnson Services, Inc. (U.S.)
• Boston Scientific Corporation (U.S.)
• Cook (U.S.)
• CONMED Corporation (U.S.)
• STERIS (U.S.)
• Henry Schein, Inc. (U.S.)
• CapsoVision, Inc. (U.S.)
• Teleflex Incorporated (U.S.)
• FUJIFILM Holdings Corporation (Japan)
• Olympus Corporation (Japan)
• Hoya Corporation (Japan)
• Smith+Nephew (UK)
• Ambu A/S (Denmark)
• SonoScape Medical Corp (China)
• KLS Martin Group (Germany)
• Laborie (Canada)
• Micro-Tech Endoscopy (China)
• Jiangsu Vedkang (China)
• JINSHAN Science & Technology (China)
• INTROMEDIC (South Korea)
• Ovesco Endoscopy AG (Germany)
• Erbe Elektromedizin GmbH (Germany)
• Mitra Industries Pvt. Ltd. (India)

ページTOPに戻る


Table of Contents

TABLE OF CONTENTS
1 INTRODUCTION 94
1.1 OBJECTIVES OF THE STUDY 94
1.2 MARKET DEFINITION 94
1.3 OVERVIEW OF THE GLOBAL GASTROINTESTINAL ENDOSCOPY MARKET 94
1.4 LIMITATIONS 96
1.5 MARKETS COVERED 96
2 MARKET SEGMENTATION 99
2.1 MARKETS COVERED 99
2.2 GEOGRAPHICAL SCOPE 100
2.3 YEARS CONSIDERED FOR THE STUDY 101
2.4 CURRENCY AND PRICING 101
2.5 DBMR TRIPOD DATA VALIDATION MODEL 102
2.6 MULTIVARIATE MODELLING 105
2.7 PRODUCT LIFELINE CURVE 106
2.8 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS 107
2.9 DBMR MARKET POSITION GRID 108
2.10 VENDOR SHARE ANALYSIS 109
2.11 MARKET END USER COVERAGE GRID 110
2.12 SECONDARY SOURCES 111
2.13 ASSUMPTIONS 111
3 EXECUTIVE SUMMARY 112
4 PREMIUM INSIGHTS 117
4.1 PESTAL ANALYSIS 120
4.2 PORTERS FIVE FORCES ANALYSIS 121
4.3 INDUSTRY INSIGHTS 122
4.3.1 MICRO AND MACROECONOMIC FACTORS 122
4.3.2 PENETRATION AND GROWTH PROSPECT MAPPING 122
4.3.3 KEY PRICING STRATEGIES 122
4.3.4 COST ANALYSIS BREAKDOWN 122
4.3.5 TECHNOLOGY ROADMAP 122
4.3.6 OPPUTUNITY MAP ANALYSIS 123
4.3.7 PRICING ANALYSIS 123
4.3.8 COMPETITOR’S MODEL ANALYSIS 123
4.3.9 HEALTHCARE ECONOMY 123
4.3.9.1 HEALTHCARE EXPENDITURE 123
4.3.9.2 CAPITAL EXPENDITURE 123
4.3.9.3 CAPEX TRENDS 124
4.3.9.4 CAPEX ALLOCATION 124
4.3.9.5 FUNDING SOURCES 124
4.3.9.6 INDUSTRY BENCHMARKS 124
4.3.9.7 GDP RATIO IN OVERALL GDP 124
4.3.9.8 HEALTHCARE SYSTEM STRUCTURE 125
4.3.9.9 GOVERNMENT POLICIES 125
4.3.9.10 ECONOMIC DEVELOPMENT 125
4.4 CURRENT TARIFF RATE (S) IN TOP-5 COUNTRY MARKETS 126
4.4.1 OUTLOOK: LOCAL PRODUCTION V/S IMPORT RELIANCE 126
4.4.2 VENDOR SELECTION CRITERIA DYNAMICS 127
4.4.3 IMPACT ON SUPPLY CHAIN 127
4.4.3.1 RAW MATERIAL PROCUREMENT 128
4.4.3.2 MANUFACTURING AND PRODUCTION 128
4.4.3.3 LOGISTICS AND DISTRIBUTION 129
4.4.3.4 PRICE PITCHING AND POSITION OF MARKET 129
4.4.4 INDUSTRY PARTICIPANTS: PROACTIVE MOVES 130
4.4.4.1 SUPPLY CHAIN OPTIMIZATION 130
4.4.4.2 JOINT VENTURE ESTABLISHMENTS 131
4.4.5 IMPACT ON PRICES 132
4.4.6 REGULATORY INCLINATION 132
4.4.6.1 GEOPOLITICAL SITUATION 133
4.4.6.2 TRADE PARTNERSHIPS BETWEEN THE COUNTRIES 133
4.4.6.3 FREE TRADE AGREEMENTS 134
4.4.6.4 ALLIANCES ESTABLISHMENTS 134
4.4.6.5 STATUS ACCREDITATION (INCLUDING MFTN) 135
4.4.6.6 DOMESTIC COURSE OF CORRECTION 135
4.4.6.7 INCENTIVE SCHEMES TO BOOST PRODUCTION OUTPUTS 136
4.4.6.8 ESTABLISHMENT OF SPECIAL ECONOMIC ZONES/INDUSTRIAL PARKS 137
4.4.7 PRICE INDEX 137
4.5 INNOVATION TRACKER AND STRATEGIC ANALYSIS 138
4.6 SUPPLY CHAIN ECOSYSTEM 140
4.7 COMPANY EVALUATION QUADRANT 141

5 REGULATORY COMPLIANCE 142
5.1 REGULATORY AUTHORITIES 142
5.2 REGULATORY CLASSIFICATIONS 143
5.3 REGULATORY SUBMISSIONS 144
5.4 INTERNATIONAL HARMONIZATION 144
5.5 COMPLIANCE AND QUALITY MANAGEMENT SYSTEMS 144
5.6 REGULATORY CHALLENGES AND STRATEGIES 144
6 MARKET OVERVIEW 145
6.1 DRIVERS 147
6.1.1 RISING PREVALENCE OF GASTROINTESTINAL DISORDERS 147
6.1.2 AGING POPULATION DRIVING INCREASED DEMAND FOR GI ENDOSCOPY 148
6.1.3 TECHNOLOGICAL ADVANCEMENTS ENHANCING GI ENDOSCOPY PROCEDURES 149
6.1.4 RISING AWARENESS AND EXPANDED SCREENING PROGRAMS FOR GASTROINTESTINAL ENDOSCOPY 150
6.2 RESTRAINTS 151
6.2.1 HIGH COST OF EQUIPMENT AND PROCEDURES 151
6.2.2 RISK OF PROCEDURE-RELATED COMPLICATIONS 152
6.3 OPPORTUNITIES 153
6.3.1 GROWING EMPHASIS ON EARLY COLORECTAL CANCER DETECTION 153
6.3.2 GROWING ADOPTION OF HOME-BASED AND CAPSULE ENDOSCOPY SOLUTIONS 154
6.3.3 INCREASING PREVALENCE AND ADVANCEMENTS IN PERSONALIZED THERAPEUTIC ENDOSCOPY 155
6.4 CHALLENGES 156
6.4.1 LIMITED ACCESS TO GI ENDOSCOPY IN RURAL AREAS 156
6.4.2 COMPLEXITIES IN ENDOSCOPE REPROCESSING AND STERILIZATION PROCESSES 157
7 GLOBAL GASTROINTESTINAL ENDOSCOPY MARKET, BY PRODUCT 158
7.1 OVERVIEW 159
7.2 GASTROINTESTINAL ENDOSCOPES & SYSTEMS 162
7.2.1 ENDOSCOPES 164
7.2.1.1 COLONOSCOPES 165
7.2.1.2 GASTROSCOPES 165
7.2.1.3 DUODENOSCOPES 165
7.2.1.4 ENTEROSCOPES 165
7.2.1.5 SIGMOIDOSCOPES 165
7.2.1.6 RESECTOSCOPES 165

7.2.2 FLEXIBLE 166
7.2.3 RIGID 166
7.2.4 SEMI RIGID 166
7.2.4.1 VIDEO 167
7.2.4.2 FIBRE 167
7.2.4.3 ULTRASONIC 167
7.2.5 VISUALIZATION SYSTEMS 168
7.2.5.1 FLUORESCENCE IMAGING SYSTEMS 168
7.2.5.1.1 NIR LIGHT FLUORESCENCE IMAGING SYSTEM 169
7.2.5.1.2 WHITE LIGHT FLUORESCENCE IMAGING SYSTEM 169
7.2.5.1.3 UV LIGHT FLUORESCENCE IMAGING SYSTEMS 169
7.2.5.1.4 CONFOCAL LASER ENDOSCOPY IMAGING SYSTEMS 169
7.2.5.1.5 PROBE-BASED CLE (PCLE) 170
7.2.5.1.6 BUILT-IN DEVICE CLE (ECLE) 170
7.2.5.2 HIGH DEFINITION (HD) VISUALIZATION SYSTEMS 171
7.2.5.2.1 2D SYSTEMS 171
7.2.5.2.2 3D SYSTEMS 171
7.2.5.3 STANDARD DEFINITION (SD) VISUALIZATION SYSTEMS 172
7.2.5.3.1 ENDOSCOPIC ULTRASONOGRAPHY SYSTEMS 172
7.2.5.3.2 CAPSULE ENDOSCOPES 172
7.2.5.3.3 ULTRASOUND DEVICE 172
7.3 GASTROINTESTINAL ENDOTHERAPY 173
7.3.1 ERCP DEVICES 175
7.3.2 BIOPSY DEVICE 175
7.3.3 STENTING AND DILATION DEVICE 175
7.3.4 HOMEOSTASIS DEVICES 175
7.3.4.1 LIGATION DEVICES 176
7.3.4.2 PROBES 176
7.3.4.3 SCLEROTHERAPY NEEDLES 176
7.3.5 RETRIEVAL DEVICES 177
7.3.6 CAMERA HEAD 177
7.3.7 ANTI-REFLUX DEVICES 177
7.3.7.1 TRANSORAL INCISIONLESS FUNDOPLICATION (TIF) DEVICES 177
7.3.7.2 TRANSESOPHAGEAL RADIOFREQUENCY (RF) ANTI-REFLUX DEVICES 177
7.3.8 OTHERS 178

8 GLOBAL GASTROINTESTINAL ENDOSCOPY MARKET, BY PROCEDURE TYPE 179
8.1 OVERVIEW 180
8.2 COLONOSCOPY 183
8.3 GASTROSCOPY 184
8.4 DUODENOSCOPY 184
8.5 ENTEROSCOPY 185
8.6 SIGMOIDOSCOPY 185
8.7 OTHERS 186
9 GLOBAL GASTROINTESTINAL ENDOSCOPY MARKET, BY USABILITY 187
9.1 OVERVIEW 188
9.2 REUSABLE 191
9.3 DISPOSABLE/ SINGLE USE 192
10 GLOBAL GASTROINTESTINAL ENDOSCOPY MARKET, BY APPLICATION 193
10.1 OVERVIEW 194
10.2 TREATMENT 197
10.3 DIAGNOSIS 198
11 GLOBAL GASTROINTESTINAL ENDOSCOPY MARKET, BY END USER 199
11.1 OVERVIEW 200
11.2 HOSPITALS 204
11.3 AMBULATORY SURGICAL CENTERS 205
11.4 SPECIALTY CLINICS 206
11.5 LABORATORIES 206
11.6 OTHERS 207
12 GLOBAL GASTROINTESTINAL ENDOSCOPY MARKET, BY DISTRIBUTION CHANNEL 208
12.1 OVERVIEW 209
12.2 DIRECT TENDER 212
12.3 RETAIL SALES 213
12.4 OTHERS 213
13 GLOBAL GASTROINTESTINAL ENDOSCOPY MARKET, BY REGION 214
13.1 OVERVIEW 215
13.2 NORTH AMERICA 218
13.2.1 U.S. 234
13.2.2 CANADA 249
13.2.3 MEXICO 263

13.3 EUROPE 277
13.3.1 GERMANY 292
13.3.2 FRANCE 305
13.3.3 U.K. 319
13.3.4 ITALY 332
13.3.5 SPAIN 344
13.3.6 RUSSIA 356
13.3.7 SWITZERLAND 368
13.3.8 NETHERLANDS 380
13.3.9 POLAND 392
13.3.10 TURKEY 404
13.3.11 REST OF EUROPE 417
13.4 ASIA-PACIFIC 418
13.4.1 CHINA 432
13.4.2 JAPAN 445
13.4.3 INDIA 458
13.4.4 SOUTH KOREA 471
13.4.5 AUSTRALIA 483
13.4.6 INDONESIA 495
13.4.7 THAILAND 508
13.4.8 MALAYSIA 520
13.4.9 PHILIPPINES 532
13.4.10 SINGAPORE 544
13.4.11 VIETNAM 557
13.4.12 REST OF ASIA-PACIFIC 569
13.5 SOUTH AMERICA 570
13.5.1 BRAZIL 584
13.5.2 ARGENTINA 597
13.5.3 REST OF SOUTH AMERICA 610
13.6 MIDDLE EAST AND AFRICA 611
13.6.1 SOUTH AFRICA 625
13.6.2 SAUDI ARABIA 638
13.6.3 U.A.E 651
13.6.4 EGYPT 664
13.6.5 ISRAEL 676
13.6.6 KUWAIT 689
13.6.7 REST OF MIDDLE EAST AND AFRICA 702

14 GLOBAL GASTROINTESTINAL ENDOSCOPY MARKET: COMPANY LANDSCAPE 703
14.1 COMPANY SHARE ANALYSIS: GLOBAL 703
14.2 COMPANY SHARE ANALYSIS: NORTH AMERICA 704
14.3 COMPANY SHARE ANALYSIS: EUROPE 705
14.4 COMPANY SHARE ANALYSIS: ASIA-PACIFIC 706
15 SWOT ANALYSIS 707
16 COMPANY PROFILES 708
16.1 OLYMPUS CORPORATION 708
16.1.1 COMPANY SNAPSHOT 708
16.1.2 REVENUE ANALYSIS 708
16.1.3 COMPANY SHARE ANALYSIS 709
16.1.4 PRODUCT PORTFOLIO 709
16.1.5 RECENT DEVELOPMENT/NEWS 711
16.2 FUJIFILM HOLDINGS CORPORATION 712
16.2.1 COMPANY SNAPSHOT 712
16.2.2 REVENUE ANALYSIS 712
16.2.3 COMPANY SHARE ANALYSIS 713
16.2.4 PRODUCT PORTFOLIO 713
16.2.5 RECENT DEVELOPMENTS/NEWS 714
16.3 MEDTRONIC 716
16.3.1 COMPANY SNAPSHOT 716
16.3.2 REVENUE ANALYSIS 716
16.3.3 COMPANY SHARE ANALYSIS 717
16.3.4 PRODUCT PORTFOLIO 717
16.3.5 RECENT DEVELOPMENTS/NEWS 719
16.4 JOHNSON & JOHNSON SERVICES, INC. 720
16.4.1 COMPANY SNAPSHOT 720
16.4.2 REVENUE ANALYSIS 720
16.4.3 COMPANY SHARE ANALYSIS 721
16.4.4 PRODUCT PORTFOLIO 721
16.4.5 RECENT DEVELOPMENTS 721
16.5 STRYKER 722
16.5.1 COMPANY SNAPSHOT 722
16.5.2 REVENUE ANALYSIS 722
16.5.3 COMPANY SHARE ANALYSIS 723
16.5.4 PRODUCT PORTFOLIO 723
16.5.5 RECENT DEVELOPMENT 724

16.6 AMBU AS 725
16.6.1 COMPANY SNAPSHOT 725
16.6.2 REVENUE ANALYSIS 725
16.6.3 PRODUCT PORTFOLIO 726
16.6.4 RECENT DEVELOPMENTS/NEWS 727
16.7 ANX ROBOTICS 728
16.7.1 COMPANY SNAPSHOT 728
16.7.2 PRODUCT PORTFOLIO 728
16.7.3 RECENT DEVELOPMENTS/NEWS 729
16.8 BOSTON SCIENTIFIC CORPORATION 730
16.8.1 COMPANY SNAPSHOT 730
16.8.2 REVENUE ANALYSIS 730
16.8.3 PRODUCT PORTFOLIO 731
16.8.4 RECENT DEVELOPMENT 733
16.9 CAPSOVISION, INC. 734
16.9.1 COMPANY SNAPSHOT 734
16.9.2 PRODUCT PORTFOLIO 734
16.9.3 RECENT DEVELOPMENTS/NEWS 735
16.10 CONMED CORPORATION 736
16.10.1 COMPANY SNAPSHOT 736
16.10.2 PRODUCT PORTFOLIO 737
16.10.3 RECENT DEVELOPMENTS 740
16.11 COOK 741
16.11.1 COMPANY SNAPSHOT 741
16.11.2 PRODUCT PORTFOLIO 741
16.11.3 RECENT DEVELOPMENT/NEWS 743
16.12 DAICHUAN MEDICAL 744
16.12.1 COMPANY SNAPSHOT 744
16.12.2 PRODUCT PORTFOLIO 744
16.12.3 RECENT DEVELOPMENT 744
16.13 ERBE ELEKTROMEDIZIN GMBH 745
16.13.1 COMPANY SNAPSHOT 745
16.13.2 PRODUCT PORTFOLIO 745
16.13.3 RECENT DEVELOPMENT 747
16.14 GONGJIANG ENDOSCOPY INSTRUMENTS CO., LTD 748
16.14.1 COMPANY SNAPSHOT 748
16.14.2 PRODUCT PORTFOLIO 748
16.14.3 RECENT DEVELOPMENT 748

16.15 HENRY SCHEIN, INC. 749
16.15.1 COMPANY SNAPSHOT 749
16.15.2 REVENUE ANALYSIS 749
16.15.3 PRODUCT PORTFOLIO 750
16.15.4 RECENT DEVELOPMENT 750
16.16 HOYA CORPORATION. 751
16.16.1 COMPANY SNAPSHOT 751
16.16.2 REVENUE ANALYSIS 751
16.16.3 PRODUCT PORTFOLIO 752
16.16.4 RECENT DEVELOPMENT 754
16.17 INTROMEDIC 755
16.17.1 COMPANY SNAPSHOT 755
16.17.2 PRODUCT PORTFOLIO 755
16.17.3 RECENT DEVELOPMENT 755
16.18 JIANGSU VEDKANG MEDICAL SCIENCE AND TECHNOLOGY CO., LTD 756
16.18.1 COMPANY SNAPSHOT 756
16.18.2 PRODUCT PORTFOLIO 756
16.18.3 RECENT DEVELOPMENT 758
16.19 JINSHAN SCIENCE & TECHNOLOGY 759
16.19.1 COMPANY SNAPSHOT 759
16.19.2 PRODUCT PORTFOLIO 759
16.19.3 RECENT DEVELOPMENT/NEWS 761
16.20 KLS MARTIN GROUP 762
16.20.1 COMPANY SNAPSHOT 762
16.20.2 PRODUCT PORTFOLIO 762
16.20.3 RECENT DEVELOPMENT 764
16.21 LABORIE 765
16.21.1 COMPANY SNAPSHOT 765
16.21.2 PRODUCT PORTFOLIO 765
16.21.3 RECENT DEVELOPMENT 768
16.22 MECANMEDICAL 769
16.22.1 COMPANY SNAPSHOT 769
16.22.2 PRODUCT PORTFOLIO 769
16.22.3 RECENT DEVELOPMENT 770
16.23 MICRO-TECH ENDOSCOPY 771
16.23.1 COMPANY SNAPSHOT 771
16.23.2 PRODUCT PORTFOLIO 771
16.23.3 RECENT DEVELOPMENT 773

16.24 MITRA INDUSTRIES PVT. LTD. 774
16.24.1 COMPANY SNAPSHOT 774
16.24.2 PRODUCT PORTFOLIO 774
16.24.3 RECENT DEVELOPMENT 775
16.25 OVESCO ENDOSCOPY AG 776
16.25.1 COMPANY SNAPSHOT 776
16.25.2 PRODUCT PORTFOLIO 776
16.25.3 RECENT DEVELOPMENT 778
16.26 SHAILI ENDOSCOPY 780
16.26.1 COMPANY SNAPSHOT 780
16.26.2 PRODUCT PORTFOLIO 780
16.26.3 RECENT DEVELOPMENT 782
16.27 SMITH+NEPHEW 783
16.27.1 COMPANY SNAPSHOT 783
16.27.2 REVENUE ANALYSIS 783
16.27.3 PRODUCT PORTFOLIO 784
16.27.4 RECENT DEVELOPMENT 784
16.28 SONOSCAPE MEDICAL CORP. 785
16.28.1 COMPANY SNAPSHOT 785
16.28.2 REVENUE ANALYSIS 786
16.28.3 PRODUCT PORTFOLIO 786
16.28.4 RECENT DEVELOPMENT/NEWS 788
16.29 STERIS 789
16.29.1 COMPANY SNAPSHOT 789
16.29.2 REVENUE ANALYSIS 789
16.29.3 PRODUCT PORTFOLIO 790
16.29.4 RECENT DEVELOPMENT 791
16.30 TELEFLEX INCORPORATED. 792
16.30.1 COMPANY SNAPSHOT 792
16.30.2 REVENUE ANALYSIS 792
16.30.3 PRODUCT PORTFOLIO 793
16.30.4 RECENT DEVELOPMENT 794
17 QUESTIONNAIRE 795

 

ページTOPに戻る

ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。

webからのご注文・お問合せはこちらのフォームから承ります

本レポートと同じKEY WORD()の最新刊レポート

  • 本レポートと同じKEY WORDの最新刊レポートはありません。

よくあるご質問


Data Bridge Market Research社はどのような調査会社ですか?


データブリッジマーケットリサーチ(Data Bridge Market Research)は500名以上の多様な分野のアナリストが所属するインドの調査会社です。 もっと見る


調査レポートの納品までの日数はどの程度ですか?


在庫のあるものは速納となりますが、平均的には 3-4日と見て下さい。
但し、一部の調査レポートでは、発注を受けた段階で内容更新をして納品をする場合もあります。
発注をする前のお問合せをお願いします。


注文の手続きはどのようになっていますか?


1)お客様からの御問い合わせをいただきます。
2)見積書やサンプルの提示をいたします。
3)お客様指定、もしくは弊社の発注書をメール添付にて発送してください。
4)データリソース社からレポート発行元の調査会社へ納品手配します。
5) 調査会社からお客様へ納品されます。最近は、pdfにてのメール納品が大半です。


お支払方法の方法はどのようになっていますか?


納品と同時にデータリソース社よりお客様へ請求書(必要に応じて納品書も)を発送いたします。
お客様よりデータリソース社へ(通常は円払い)の御振り込みをお願いします。
請求書は、納品日の日付で発行しますので、翌月最終営業日までの当社指定口座への振込みをお願いします。振込み手数料は御社負担にてお願いします。
お客様の御支払い条件が60日以上の場合は御相談ください。
尚、初めてのお取引先や個人の場合、前払いをお願いすることもあります。ご了承のほど、お願いします。


データリソース社はどのような会社ですか?


当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
世界各国の「市場・技術・法規制などの」実情を調査・収集される時には、データリソース社にご相談ください。
お客様の御要望にあったデータや情報を抽出する為のレポート紹介や調査のアドバイスも致します。



詳細検索

このレポートへのお問合せ

03-3582-2531

電話お問合せもお気軽に

 

 

2025/10/21 10:26

151.56 円

176.95 円

205.98 円

ページTOPに戻る